ÂÜÀòÂÒÂ×

The Leadership Team at Tyra Biosciences is responsible for setting the strategic direction and vision of the company as it develops innovative oncology treatments targeting acquired resistance pathways. Comprising key executives including the CEO, COO, and C-suite leaders in science, technology, and medical development, the team collaborates to align resources, drive research efforts, and ensure effective execution of product development to ultimately enhance patient outcomes.